Next Article in Journal
Curing the Curable: Managing Low-Risk Acute Lymphoblastic Leukemia in Resource Limited Countries
Next Article in Special Issue
Deep Infiltrating Endometriosis and Adenomyosis: Implications on Pregnancy and Outcome
Previous Article in Journal
Postmortem Micro-CT of Human Fetal Heart—A Systematic Literature Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Postoperative Pain Is Driven by Preoperative Pain, Not by Endometriosis

by
Panagiotis Kanellos
1,
Konstantinos Nirgianakis
1,
Franziska Siegenthaler
1,
Christian Vetter
2,
Michael D. Mueller
1 and
Sara Imboden
1,*
1
Department of Gynecology and Obstetrics, Bern University Hospital, University of Bern, 3010 Bern, Switzerland
2
Department of Anesthesiology and Pain Medicine, Bern University Hospital, University of Bern, 3010 Bern, Switzerland
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2021, 10(20), 4727; https://doi.org/10.3390/jcm10204727
Submission received: 27 August 2021 / Revised: 8 October 2021 / Accepted: 13 October 2021 / Published: 15 October 2021
(This article belongs to the Special Issue Endometriosis: Current Perspectives on Diagnosis and Treatment)

Abstract

:
(1) Background: The aim of this study was to evaluate the impact of endometriosis on postoperative pain following laparoscopic hysterectomy; (2) Methods: A total of 214 women who underwent a laparoscopic hysterectomy between January 2013 and October 2017 were divided into four subgroups as follows: (1) endometriosis with chronic pain before the surgery (n = 57); (2) pain-free endometriosis (n = 50); (3) pain before the surgery without endometriosis (n = 40); (4) absence of both preoperative pain and endometriosis (n = 67). Postoperative pain was compared by using Visual Analog Scale (VAS) scores and by tracking the use of painkillers during the day of surgery and the first two postoperative days; (3) Results: Women with chronic pain before the surgery reported higher VAS scores during the first postoperative days, while the use of analgesics was similar across the groups. There was no difference in the postoperative pain when comparing endometriosis patients to non-endometriosis patients; (4) Conclusions: Women with chronic pelvic pain demonstrated increased postoperative pain after laparoscopic hysterectomy, which was independent of the presence or severity of endometriosis. The increased VAS scores did not, however, translate into equally greater use of painkillers, possibly due to the standardised protocols of analgesia in the immediate postoperative period. These findings support the need for careful postsurgical pain management in patients with pain identified as an indication for hysterectomy, independent of the extent of the surgery or underlying diagnosis.

1. Introduction

Endometriosis, defined as the presence of endometrial glands outside the uterine cavity, affects 10–15% of women of reproductive age [1]. Chronic pelvic pain (CPP) and painful menstruation (dysmenorrhea) are the main symptoms; secondary symptoms reported are painful intercourse (dyspareunia), painful defecation (dyschezia), painful urination (dysuria), and infertility [2]. CPP is defined as pain that occurs below the umbilicus and persists for at least 6 months [3,4]. In addition to endometriosis, many other gynaecological and non-gynaecological causes of CPP have been described, including adhesions, pelvic inflammatory disease, irritable bowel syndrome, interstitial cystitis, etc. [5]. The prevalence of endometriosis in women with CPP has been a topic of discussion; it varies between 25% and 70% [6,7]. The simultaneous co-existence of two or more associated causes is not rare [8].
Hysterectomy is the most common surgical procedure performed in non-pregnant women [9]; approximately, 12 to 17% of such surgeries are carried out due to CPP [10]; Acute postoperative pain is common. Nearly 20% of patients experience severe pain in the first 24 h after surgery [11]. Factors predictive of severe acute postoperative pain include younger age, female gender, increased body mass index, preoperative pain, preoperative use of opioids, and general anaesthesia [12]. Cognitive factors and affective responses, such as pain catastrophising, and psychological factors such as depression have also been proven to influence the course of acute pain after hysterectomy [13]. Multiple guidelines exist regarding postoperative analgesia, yet most are not specialty specific [14]; it is known, meanwhile, that gynaecologic surgeons tend to prescribe 2 to 4 times more opioids than the patients need after a laparoscopic hysterectomy [15,16].
It has been shown that women with endometriosis experience a decreased pain threshold and therefore a higher pain perception after noxious stimuli [17]. However, studies of patients with CPP have shown similar findings [18,19]. Treatment of central sensitisation is challenging; in the past, the focus has been placed on centrally acting drugs (tricyclic compounds, serotonin–norepinephrine reuptake inhibitors, etc.) without significant success [20]. Understanding whether the increased pain sensitivity is linked to the endometrial tissue itself, or whether it is the outcome of the chronic pain, unrelated to the presence of endometriosis, is essential in the context of postoperative pain management: it could help optimise the use of painkillers after surgery and increase patients’ satisfaction.
The aim of this study was to determine if, and to what extent, endometriosis or pre-existing pain affects the course of acute postoperative pain (pain occurring up to 7 days after the operation) experienced by women undergoing a total laparoscopic hysterectomy.

2. Materials and Methods

This retrospective study included patients between 19 and 51 years of age with signed general consent who underwent a total laparoscopic hysterectomy between January 2013 and October 2017 due to a non-malignant cause in the Department of Gynaecology of the Bern University Hospital, Switzerland. Clinical data were obtained from the patients’ electronic medical records. Information regarding patients’ demographics and medical history were collected (Body Mass Index (BMI), number of previous abdominal surgeries, parity, use of hormones before the operation). Attention was paid to the indication for the surgery, focusing on the expression of pain before the operation. The patients were divided into 2 groups: for the first group, hysterectomy was indicated or partly indicated by pain, while the second group reported no pain symptoms before the operation. When one of the terms 1. chronic pelvic pain, 2. dysmenorrhea, 3. dyspareunia, 4. dysuria, or 5. dyschezia was found under preoperative diagnosis or clinical indication included in the operative report, the patient was assigned to the first group; otherwise, she was classified as non-pain patient and registered in the second group. Further indications for surgery that were recorded include abnormal vaginal bleeding, cervical dysplasia, growing fibroids, sex reassignment surgery (-female- to -male-), Lynch syndrome, Breast Cancer gene (BRCA) mutation, uterine prolapse, and uterine polyps. The following surgical parameters were evaluated: duration of the operation, estimated blood loss, uterine morcellation, and complications during or after the operation, using the Clavien–Dindo classification [21]. In some cases, laparoscopic hysterectomy was combined with other interventions (adnexal surgery, removal of endometriosis, adhesiolysis, cystoscopy, and appendectomy). All surgeries were minimally invasive; 14 hysterectomies were robotic assisted using the da Vinci surgical system. The presence of endometriosis was confirmed either through histopathology or as a macroscopic finding, described in the surgical report. To describe the extent of endometriosis, the revised American Society for Reproductive Medicine (rASRM) classification (for peritoneal endometriosis), and the ENZIAN classification (for deep infiltrating endometriosis) were applied [22]. Peritoneal endometriosis classified as rASRM III or IV was considered to be severe endometriosis. Adenomyosis, defined as endometrial glands found in the uterine myometrium has, according to most of the current literature, different pathogenesis to endometriosis. However, there is a strong association between them, including similar clinical manifestation, frequent co-prevalence, and partly common molecular origin [23]. Therefore, cases of histologically confirmed adenomyosis without other endometriosis were also included in the endometriosis group in this study. Other histological findings of the uterus reported were fibroids, dysplasia of the cervix, polyps, and placental remnants.
The primary outcome was postoperative pain during the first 3 days of the hospital stay (day of surgery as well as the first two postoperative days). Two different methods of pain evaluation were applied: the visual analogue scale (VAS) score, recorded at least 3 times a day, and the use of analgesics. For the latter, the pain point system scale (PPSS) was applied [24]. The average VAS scores, as well as the lowest and highest VAS scores for each day of the hospital stay, were registered and compared. PPSS is a proven instrument for quantifying the use of painkillers in the context of retrospective studies: one dose of paracetamol 600 mg equals 1 point; a dose of paracetamol 500 mg plus 10 mg codeine equals 3 points; each dose of a nonsteroidal anti-inflammatory drug (diclofenac 75 mg, parecoxib 40 mg, or lornoxicam 8 mg) equals 3 points; and each dose of an opioid (tramadol 50 mg or dextropropoxyphene hydrochloride 75 mg or pethidine hydrochloride 50 mg) equals 7 points. When other painkillers in each category were administered, they were converted using universally accepted conversion scales: opioid morphine milligram equivalent and the Appendix of Comparable Non-Steroidal Anti-Inflammatory Drugs (NSAID) Dose Levels [25]. Secondary outcomes were the duration of hospital stay, the number of visits by the attending gynaecologist that were recorded in the electronic files, and the use of epidural anaesthesia or patient-controlled analgesia (PCA).
Each patient was assigned to one of the following four categories based on the indication for the hysterectomy and the presence of endometriosis or not: (1) endometriosis with preoperative pain (endo+/pain+); (2) preoperative pain without endometriosis (endo−/pain+); (3) endometriosis without preoperative pain (endo+/pain−); (4) no endometriosis and no preoperative pain (endo−/pain−).
Ethics approval for this research was obtained from the Ethics Commission of the Canton of Bern, Switzerland (Reference Number: 2020-00937).

Statistical Analysis

Statistical analysis was performed using IBM SPSS Statistics (version 25.0). For patient and clinical–pathological analyses, basic descriptive statistics were applied. To compare the characteristics within the groups, the chi-squared test and ANOVA were used. A non-parametric test was applied for variables not meeting the assumptions of the t-test equivalent. Due to the increased likelihood of type II errors, adjustments for multiple testing were avoided [26]. All tests were two sided, and p values were considered statistically significant when <0.05.

3. Results

After the inclusion criteria were applied, 214 women were included in the study. Patient characteristics are summarised in Table 1. The median age was 40.63 (25–51) years at the time of surgery. There were no significant differences among the groups in age, body mass index, and the number of prior pregnancies. Women with endometriosis had a higher number of prior abdominal surgeries for pelvic pain or endometriosis. In the study, 26.2% (n = 56) of the patients underwent a simple laparoscopic hysterectomy; in 46.7% (n = 100) of the women, additional adnexal surgery was performed. For the rest of the collective, further interventions were recorded.
The surgery-related data are summarised in Table 2. For 53.3% (n = 57) of the women in the endometriosis group, a peritoneal or deep infiltrating endometriosis was reported. The rest displayed isolated adenomyosis uteri. Endometriosis was histologically confirmed in 47 cases. Severe peritoneal endometriosis (defined as endometriosis rAFS III and IV) was observed in 14 women and deep infiltrating endometriosis in 27 patients.

3.1. Postoperative Pain

Table 3 provides a summary of the postoperative pain and the medication received on the first three days after laparoscopic hysterectomy. Independent t-tests for statistical significance between groups were conducted; patients with pain symptoms before the operation reported significantly higher VAS scores (minimum, mean, maximum) during the first day (Figure 1), while the consumption of painkillers was statistically similar. The maximum Visual Analog Scale (VAS) score during the second observation day (p-value = 0.014), the mean VAS score during the third day (p-value = 0.017), and the maximum VAS score during the third day (p-value = 0.028) were also higher for patients with preoperative pain (Table 4). There was no statistical correlation between the presence or the extent of endometriosis and postoperative pain (Table 5).

3.2. Secondary Pain Outcomes

3.2.1. Patient Controlled Analgesia (PCA)

  • Endo+/pain+: 8 patients (14%) used PCA for an average of 2 days.
  • Endo−/pain+: 2 patients (4%) used PCA for an average of 2 days.
  • Endo+/pain−: 3 patients (7.5%) used PCA for an average of 2.7 days.
  • Endo−/pain−: 4 patients (6%) used PCA for an average of 2.25 days.

3.2.2. Frequency of Doctor’s Visits

The number of doctor’s bedside visits (as extracted from the electronic files) was statistically higher for patients reporting pain symptoms before the surgery (3.01 vs. 2.84 during the total duration of the hospital stay, p-value < 0.001). The presence of endometriosis did not play a significant role.

3.2.3. Duration of the Hospital Stay

Patients with endometriosis or preoperative pain tended to have a shorter hospital stay, compared with the group endo−/pain− (3.67 days vs. 3.78 days, p-value < 0.001). No other difference was found between the groups.

4. Discussion

In line with the results found in most of the current literature, our study shows that women with pain before the operation experience increased postoperative pain after laparoscopic hysterectomy. Our findings did not appear to be related to the presence or severity of endometriosis [27,28,29,30,31]. Our results are in line with the growing evidence that patients with diverse pain syndromes face a cardinal problem of pain amplification. Compared with the pain-free group, these patients report enhanced pain intensity and display augmented neuronal activity in pain-related regions of the brain when exposed to stimuli that healthy individuals find innocuous [32,33]. In the end, even in the absence of true pain, the receptors would remain activated, leading to chronic pain syndrome.
Surprisingly, the increased VAS scores of the groups with pain before the operation did not generate an analogous use of analgesics, as the PPSS was similar between the groups. This finding is presumably associated with the standardised pain management protocols applied nowadays. Most patients who undergo surgical procedures experience acute postoperative pain, but evidence suggests that less than half report adequate postoperative pain relief. Individual postoperative pain management is known to still need improvement [34] since insufficient pain management has negative psychological consequences for the patients affected and leads to increased morbidity and increased health care costs [35]. The latter is reflected in our study by the frequency of the doctors’ bedside visits, which was higher for the group of patients with CPP before the operation.
In our analysis, nearly 45% of women undergoing hysterectomy for benign indications reported pain before the operation, a prevalence higher than the one previously reported of 10–32% [10,36,37]. Uccella et al. found that the presence of endometriosis is associated with longer surgical time and increased morbidity related to total laparoscopic hysterectomy [38]; other studies support this statement [39]. In this study, no difference was found in the surgical time, blood loss, and the Clavien–Dindo complications between the groups. Moreover, previous reviews showed that women undergoing laparoscopic hysterectomy tended to be of lower parity and lower BMI when endometriosis or adenomyosis uteri was present [6]. There was no difference between parity and BMI in our study groups.
What makes this study unique is the use of multiple standardised parameters to assess postoperative pain—namely, the VAS score, the PPSS, and secondary variables. Further strengths of this study are the precise patient selection and the division into subgroups based on the visualisation of the endometriosis by the surgeon or/and the histopathological reports.
However, due to its retrospective nature, this study has some important limitations. Information about the presence of pain before the operation was extracted from the hospital’s electronic database. Although a VAS questionnaire (to assess the degree of dysmenorrhea, abdominal pain, dyspareunia, dysuria, and dyschezia during the previous four weeks) was handed to all patients before the surgery, as part of other prospective studies, only 35% of our study population answered the questionnaire. Furthermore, different high-volume endoscopic surgeons performed most laparoscopic hysterectomies included in this study, and thus, it is possible that our findings may not be directly applicable to other settings. Additionally, as acute postoperative pain is defined as the pain occurring during the first 7 days after the surgery, assessing only the first 3 days can lead to bias. Finally, although the groups were relatively homologous, they included predominantly Caucasian women living in a specific region of central Europe.

5. Conclusions

Women with chronic pelvic pain demonstrate an amplified pain perception during the first days after laparoscopic hysterectomy; postsurgical pain does not correlate with the presence or extent of endometriosis. However, the increased pain does not translate into a corresponding administration of painkillers, possibly due to the standardised protocols of analgesia in the immediate postoperative period. In the era of personalised medicine, postoperative pain management should focus on the surgical approach and individual patient characteristics, such as pain before operation. Optimising the management of acute postoperative pain is crucial, as it is one of the main risk factors for developing chronic postoperative pain [27,28,29].

Author Contributions

Conceptualisation, P.K., M.D.M. and S.I.; methodology, P.K. and S.I.; software, P.K.; validation, K.N., F.S., C.V. and M.D.M.; formal analysis, P.K.; investigation, P.K. and S.I.; resources, P.K.; data curation, P.K.; writing—original draft preparation, P.K.; writing—review and editing, K.N., F.S., C.V., M.D.M. and S.I.; visualisation, P.K. and S.I.; supervision, M.D.M. and S.I.; project administration, P.K. and S.I. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Commission of the Canton of Bern, Switzerland (Reference Number: 2020-00937).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

All data involved in this study will be made available by the corresponding author upon request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Giudice, L.C.; Kao, L.C. Endometriosis. Lancet 2004, 364, 1789–1799. [Google Scholar] [CrossRef]
  2. Sinaii, N.; Plumb, K.; Cotton, L.; Lambert, A.; Kennedy, S.; Zondervan, K.; Stratton, P. Differences in characteristics among 1000 women with endometriosis based on extent of disease. Fertil. Steril. 2008, 89, 538–545. [Google Scholar] [CrossRef] [Green Version]
  3. Wozniak, S. Chronic pelvic pain. Ann. Agric. Environ. Med. 2016, 23, 223–226. [Google Scholar] [CrossRef] [PubMed]
  4. Speer, L.M.; Mushkbar, S.; Erbele, T. Chronic Pelvic Pain in Women. Am. Fam. Phys. 2016, 93, 380–387. [Google Scholar]
  5. Siedentopf, F.; Sillem, M. Chronic pelvic pain in women. Schmerz 2014, 28, 300–304. [Google Scholar] [CrossRef]
  6. Mowers, E.L.; Lim, C.S.; Skinner, B.; Mahnert, N.; Kamdar, N.; Morgan, D.M.; As-Sanie, S. Prevalence of Endometriosis during Abdominal or Laparoscopic Hysterectomy for Chronic Pelvic Pain. Obstet. Gynecol. 2016, 127, 1045–1053. [Google Scholar] [CrossRef] [PubMed]
  7. Carter, J.E. Combined hysteroscopic and laparoscopic findings in patients with chronic pelvic pain. J. Am. Assoc. Gynecol. Laparosc. 1994, 2, 43–47. [Google Scholar] [CrossRef]
  8. Tirlapur, S.A.; Kuhrt, K.; Chaliha, C.; Ball, E.; Meads, C.; Khan, K.S. The ‘evil twin syndrome’ in chronic pelvic pain: A systematic review of prevalence studies of bladder pain syndrome and endometriosis. Int. J. Surg. 2013, 11, 233–237. [Google Scholar] [CrossRef] [Green Version]
  9. Wright, J.D.; Herzog, T.J.; Tsui, J.; Anath, C.V.; Lewin, S.N.; Lu, Y.S.; Neugut, A.I.; Hershman, D.L. Nationwide trend in the performance of inpatient hysterectomy in the United States. Obstet. Gynecol. 2013, 122, 233–241. [Google Scholar] [CrossRef]
  10. Whiteman, M.K.; Hillis, S.D.; Jamieson, D.J.; Morrow, B.; Podgornik, M.N.; Brett, K.M.; Marchbanks, P.A. Inpatient hysterectomy surveillance in the United States, 2000–2004. Am. J. Obstet. Gynecol. 2008, 198, 34.e1–34.e7. [Google Scholar] [CrossRef]
  11. Small, C.; Laycock, H. Acute postoperative pain management. J. Br. Surg. 2020, 107, e70–e80. [Google Scholar] [CrossRef] [PubMed]
  12. Ip, H.Y.V.; Abrishami, A.; Peng, P.W.H.; Wong, J.; Chung, F. Predictors of postoperative pain and analgesic consumption: A qualitative systematic review. Anesthesiology 2009, 111, 657–677. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Pinto, P.R.; McIntyre, T.; Almeida, A.; Araujo-Soares, V. The mediating role of pain catastrophizing in the relationship between presurgical anxiety and acute postsurgical pain after hysterectomy. Pain 2012, 153, 218–226. [Google Scholar] [CrossRef] [Green Version]
  14. Blanton, E.; Lamvu, G.; Patanwala, I.; Barron, K.I.; Witzeman, K.; Tu, F.F.; As-Sanie, S. Non-opioid pain management in benign minimally invasive hysterectomy: A systematic review. Am. J. Obs. Gynecol. 2017, 216, 557–567. [Google Scholar] [CrossRef] [PubMed]
  15. Wong, M.; Vogell, A.; Wright, K.; Isaacson, K.; Loring, M.; Morris, S. Opioid use after laparoscopic hysterectomy: Prescriptions, patient use, and a predictive calculator. Am. J. Obstet. Gynecol. 2019, 220, 259.e1–259.e11. [Google Scholar] [CrossRef]
  16. As-Sanie, S.; Till, S.R.; Mowers, E.L.; Lim, C.S.; Skinner, B.D.; Fritsch, L.; Tsodikov, A.; Dalton, V.K.; Clauw, D.J.; Brummett, C.M. Opioid Prescribing Patterns, Patient Use, and Postoperative Pain After Hysterectomy for Benign Indications. Obstet. Gynecol. 2017, 130, 1261–1268. [Google Scholar]
  17. Van Aknen, M.; Oosterman, J.; van Rijm, T.; Woudsma, K.; Ferdek, M.; Ruigt, G.; Kozicz, T.; Braat, D.; Peeters, A.; Nap, A. Experimental pain tolerance is decreased and independent of clinical pain intensity in patients with endometriosis. Fertil. Steril. 2018, 110, 1118–1128. [Google Scholar] [CrossRef] [Green Version]
  18. As Sanie, S.; Harris, R.E.; Harte, S.E.; Tu, F.F.; Nashewat, G.; Clauw, D.J. Increased pressure pain sensitivity in women with chronic pelvic pain. Obstet. Gynecol. 2013, 122, 1047–1055. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Giamberardino, M.A.; Tana, C.; Costantini, R. Pain thresholds in women with chronic pelvic pain. Curr. Opin. Obstet. Gynecol. 2014, 26, 253–259. [Google Scholar] [CrossRef] [PubMed]
  20. Nijs, J.; Leysen, L.; Vanlauwe, J.; Logghe, T.; Ickmans, K.; Polli, A.; Malfliet, A.; Coppieters, I.; Huysmans, E. Treatment of central sensitization in patients with chronic pain: Time for change? Expert Opin. Pharm. 2019, 20, 1961–1970. [Google Scholar] [CrossRef]
  21. Dindo, D.; Demartines, N.; Clavien, P.A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004, 240, 205–213. [Google Scholar] [CrossRef] [PubMed]
  22. Haas, D.; Oppelt, P.; Shebl, O.; Shamiyeh, A.; Schimetta, W.; Mayer, R. Enzian classification: Does it correlate with clinical symptoms and the rASRM score? Acta Obstet. Gynecol. Scand. 2013, 92, 562–566. [Google Scholar] [CrossRef]
  23. Guo, S.W. The Pathogenesis of Adenomyosis vis-à-vis Endometriosis. J. Clin. Med. 2020, 9, 485. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Gkotsi, A.; Petsas, D.; Sakalis, V.; Fotas, A.; Triantafyllidis, A.; Vouros, I.; Saridakis, E.; Salpiggidis, G.; Papathanasiou, A. Pain point system scale (PPSS): A method for postoperative pain estimation in retrospective studies. J. Pain Res. 2012, 5, 503–510. [Google Scholar]
  25. Chou, R.; McDonagh, M.S.; Nakamoto, E.; Griffin, J. Analgesics for Osteoarthritis: An Update of the 2006 Comparative Effectiveness Review; Agency for Healthcare Research and Quality (US): Rockville, MD, USA, 2011. [PubMed]
  26. Perneger, T.V. What’s wrong with Bonferroni adjustments. BMJ 1998, 316, 1236–1238. [Google Scholar] [CrossRef] [PubMed]
  27. Han, C.; Ge, Z.; Jian, W.; Zhao, H.; Ma, T. Incidence and risk factors of chronic pain following hysterectomy among Southern Jiangsu Chinese Women. BMC Anesthesiol. 2017, 17, 103. [Google Scholar] [CrossRef]
  28. Brandsborg, B. Pain following hysterectomy: Epidemiological and clinical aspects. Dan. Med. J. 2012, 59, B4374. [Google Scholar]
  29. Theunissen, M.; Peters, M.L.; Schepers, J.; Maas, J.W.M.; Tournois, F.; van Suijlekom, H.A.; Gramke, H.-F.; Marcus, M.A.E. Recovery 3 and 12 months after hysterectomy: Epidemiology and predictors of chronic pain, physical functioning, and global surgical recovery. Medicine 2016, 95, e3980. [Google Scholar] [CrossRef]
  30. Sharma, L.R.; Schaldemose, E.L.; Alaverdyan, H.; Nikolajsen, L.; Chen, D.; Bhanvadia, S.; Komen, H.; Yaeger, L.; Haroutounian, S. Perioperative factors associated with persistent postsurgical pain after hysterectomy, caesarean section, prostatectomy and donor nephrectomy a systematic review and meta-analysis. Pain 2021. [Google Scholar] [CrossRef]
  31. Sommer, M.; de Rijke, J.M.; van Kleef, M.; Kessels, A.G.H.; Peters, M.L.; Geurts, J.W.; Patijin, J.; Gramke, H.-F.; Marcus, M.A.E. Predictors of acute postoperative pain after elective surgery. Clin. J. Pain 2010, 26, 87–94. [Google Scholar] [CrossRef] [PubMed]
  32. Kaya, S.; Hermans, L.; Willems, T.; Roussel, N.; Meeus, M. Central sensitization in urogynecological chronic pelvic pain: A systematic literature review. Pain Physician 2013, 16, 291–308. [Google Scholar] [CrossRef] [PubMed]
  33. As-Sanie, S.; Harris, R.E.; Napadow, V.; Kim, J.; Neshewat, G.; Kairys, A.; Williams, D.; Clauw, D.J.; Schmidt-Wilcke, T. Changes in regional gray matter volume in women with chronic pelvic pain: A voxelbased morphometry study. Pain 2012, 153, 1006–1014. [Google Scholar] [CrossRef] [Green Version]
  34. Chou, R.; Gordon, D.B.; de Leon-Casasola, O.A.; Rosenberg, J.M.; Bickler, S.; Brennan, T.; Carter, T.; Cassidy, C.L.; Chittenden, E.H.; Degenhardt, E.; et al. Management of Postoperative Pain: A Clinical Practice Guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J. Pain 2016, 17, 131–157. [Google Scholar]
  35. Joshi, G.P.; Ogunnaike, B.O. Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain. Anesthesiol. Clin. North Am. 2005, 23, 21–36. [Google Scholar] [CrossRef]
  36. Hartmann, K.E.; Ma, C.; Lamvu, G.M.; Langenberg, P.W.; Steege, J.F.; Kjerulff, K.H. Quality of life and sexual function after hysterectomy in women with preoperative pain and depression. Obstet. Gynecol. 2004, 104, 701–709. [Google Scholar] [CrossRef]
  37. Hillis, S.D.; Marchbanks, P.A.; Peterson, H.B. The effectiveness of hysterectomy for chronic pelvic pain. Obstet. Gynecol. 1995, 86, 941–945. [Google Scholar] [CrossRef]
  38. Uccella, S.; Marconi, N.; Casarin, J.; Ceccaroni, M.; Boni, L.; Sturla, D.; Serati, M.; Carollo, S.; Podesta’ Alluvion, C.; Ghezzi, F. Impact of endometriosis on surgical outcomes and complications of total laparoscopic hysterectomy. Arch. Gynecol. Obstet. 2016, 294, 771–778. [Google Scholar] [CrossRef] [PubMed]
  39. Nicolaus, K.; Zschauer, S.; Bräuer, D.; Jimenez-Cruz, J.; Lehmann, T.; Rengsberger, M.; Diebolder, H.; Runnebaum, I.B. Extensive endometriosis surgery: rASRM and Enzian score independently relate to post-operative complication grade. Arch. Gynecol. Obstet. 2020, 301, 699–706. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Comparison of the mean postoperative VAS scores during the day of the operation between patients with and without pain before the surgery (p-value = 0.004). Similar results apply for the minimum (p-value = 0.01) and maximum (p-value = 0.006) VAS scores.
Figure 1. Comparison of the mean postoperative VAS scores during the day of the operation between patients with and without pain before the surgery (p-value = 0.004). Similar results apply for the minimum (p-value = 0.01) and maximum (p-value = 0.006) VAS scores.
Jcm 10 04727 g001
Table 1. Patient characteristics.
Table 1. Patient characteristics.
Endo+/Pain+
(n = 57)
Endo+/Pain−
(n = 50)
Endo−/Pain+
(n = 40)
Endo−/Pain−
(n = 67)
Total
(n = 214)
p-Value
Age, years,
mean
40.63 (SD = 5.42)43.00 (SD = 5.19)42.38 (SD = 5.46)42.75 (SD = 7.19)42.17 (SD = 6.02)0.15
BMI, kg/m2, mean26.54 (SD = 5.45)27.14 (SD = 6.98)27.01 (SD = 5.55)27.26 (SD = 7.16)26.99 (SD = 6.36)0.94
Parity, n, mean1.18 (SD = 1.07)1.18 (SD = 1.40)1.21 (SD = 1.23)1.56 (SD = 1.42)1.30 (SD = 1.30)0.29
Previous abdominal surgeries due to pain or endometriosis, n, mean0.79 (SD = 0.88)0.36 (SD = 0.94)0.18 (SD = 0.50)00.33 (SD = 0.74)<0.05
Number of women with previous hormonal treatment, n (%)34 (59.6%)17 (34%)11 (27.5%)20 (29.9%)82 (38.3%)<0.05
Numerical variables were assessed for significance using analysis of variance (ANOVA); categorical values were assessed using the chi-squared test. BMI: Body Mass Index.
Table 2. Surgical outcomes.
Table 2. Surgical outcomes.
Endo+/Pain+
(n = 57)
Endo+/Pain−
(n = 50)
Endo−/Pain+
(n = 40)
Endo−/Pain−
(n = 67)
Total
(n = 214)
p-Value
Duration, min, mean140.67 (SD = 64.55)137.06 (SD = 53.97)122.63 (SD = 40.61)131.96 (SD = 55.41)133.72 (SD = 55.40)0.43
Blood loss, mL, mean128.07 (SD = 95.91)144.00 (SD = 139.84)130.00 (SD = 122.89)149.25 (SD = 147.58)138.79 (SD = 128.51)0.78
Number of Morcellations, n (%)5 (8.8%)16 (32%)9 (22.5%)16 (23.9%)46 (21.5%)0.03
Complications Clavien I–II, n (%)1 (1.8%)6 (12%)6 (15%)4 (6%)17 (7.9%)
Complications Clavien III–IV, n (%)2 (3.5%)2 (4%)3 (7.5%)4 (6%)11 (5.1%)0.21 *
Uterus weight, gr, mean154.37 (SD = 118.94)275.70 (SD = 231.15)291.94 (SD = 231.36)333.44 (SD = 376.37)264.58 (SD = 274.20)0.005
* The p-value refers to the total number of surgical complications; numerical variables were assessed for significance using analysis of variance (ANOVA); categorical values were assessed using the chi-squared test.
Table 3. Postoperative pain using the VAS score and the PPSS.
Table 3. Postoperative pain using the VAS score and the PPSS.
Endo+/Pain+
(n = 57)
Endo+/Pain−
(n = 50)
Endo−/Pain+
(n = 40)
Endo−/Pain−
(n = 67)
Total
(n = 214)
p-Value
VAS day 1, mean1.87 (SD = 1.60)1.34 (SD = 1.69)2.50 (SD = 2.63)1.36 (SD = 1.33)1.72 (SD = 1.82)0.014
VAS day 1, min1.23 (SD = 1.64)1.10 (SD = 1.64)2.15 (SD = 2.65)0.78 (SD = 1.33)1.24 (SD = 1.78)0.004
VAS day 1, max2.62 (SD = 2.30)1.71 (SD = 1.89)2.94 (SD = 2.77)1.95 (SD = 1.79)2.27 (SD = 2.20)0.039
PPSS day 1, mean18.0 (SD = 9.2)13.5 (SD = 9.9)15.6 (SD = 8.2)15.8 (SD = 9.1)15.8 (SD = 9.3)0.103
VAS day 2, mean1.73 (SD = 1.31)1.46 (SD = 1.47)1.90 (SD = 1.34)1.48 (SD = 1.32)1.62 (SD = 1.36)0.328
VAS day 2, min0.69 (SD = 1.07)0.77 (SD = 1.39)0.73 (SD = 1.04)0.64 (SD = 1.15)0.70 (SD = 1.16)0.944
VAS day 2, max3.29 (SD = 2.48)2.38 (SD = 2.13)3.38 (SD = 2.02)2.69 (SD = 2.23)2.90 (SD = 2.26)0.089
PPSS day 2, mean16.9 (SD = 7.1)16.0 (SD = 10.9)15.4 (SD = 7.6)15.7 (SD = 6.9)16.0 (SD = 8.2)0.799
VAS day 3, mean1.81 (SD = 1.64)1.39 (SD = 1.66)1.94 (SD = 1.87)1.14 (SD = 1.41)1.53 (SD = 1.64)0.096
VAS day 3, min1.30 (SD = 1.42)1.11 (SD = 1.56)1.48 (SD = 1.77)0.86 (SD = 1.06)1.15 (SD = 1.43)0.237
VAS day 3, max2.30 (SD = 2.14)1.76 (SD = 2.03)2.29 (SD = 2.48)1.43 (SD = 1.80)1.90 (SD = 2.10)0.148
PPSS day 3, mean10.2 (SD = 8.5)8.5 (SD = 6.4)8.8 (SD = 6.1)8.1 (SD = 7.1)8.9 (SD = 7.2)0.427
All variables were assessed for significance using analysis of variance (ANOVA). VAS: Visual Analog Scale; PPSS: pain point system scale.
Table 4. Comparison of postoperative pain between groups with and without pain before surgery.
Table 4. Comparison of postoperative pain between groups with and without pain before surgery.
Preoperative Pain
(n = 97)
No Preoperative Pain
(n = 117)
p-Value
VAS day 1, mean2.12 (SD = 2.08)1.35 (SD = 1.49)0.004
VAS day 1, min1.59 (SD = 2.01)0.92 (SD = 1.47)0.010
VAS day 1, max2.74 (SD = 2.49)1.85 (SD = 1.83)0.006
PPSS day 1, mean17.0 (SD = 8.8)14.8 (SD = 9.5)0.088
VAS day 2, mean1.80 (SD = 1.32)1.47 (SD = 1.38)0.079
VAS day 2, min0.70 (SD = 1.05)0.70 (SD = 1.25)0.958
VAS day 2, max3.33 (SD = 2.28)2.55 (SD = 2.18)0.014
PPSS day 2, mean16.3 (SD = 7.3)15.8 (SD = 8.8)0.660
VAS day 3, mean1.86 (SD = 1.73)1.25 (SD = 1.52)0.017
VAS day 3, min1.38 (SD = 1.57)0.97 (SD = 1.29)0.068
VAS day 3, max2.30 (SD = 2.27)1.57 (SD = 1.90)0.028
PPSS day 3, mean9.7 (SD = 7.6)8.3 (SD = 6.8)0.169
Table 5. Comparison of postoperative pain between groups with and without endometriosis.
Table 5. Comparison of postoperative pain between groups with and without endometriosis.
Endometriosis
(n = 107)
No Endometriosis
(n = 107)
p-Value
VAS day 1, mean1.80 (SD = 2.00)1.64 (SD = 1.66)0.575
VAS day 1, min1.30 (SD = 2.04)1.17 (SD = 1.49)0.619
VAS day 1, max2.32 (SD = 2.25)2.22 (SD = 2.17)0.743
PPSS day 1, mean15.7 (SD = 8.8)15.9 (SD = 9.8)0.891
VAS day 2, mean1.64 (SD = 1.34)1.60 (SD = 1.39)0.816
VAS day 2, min0.67 (SD = 1.10)0.73 (SD = 1.23)0.732
VAS day 2, max2.95 (SD = 2.17)2.85 (SD = 2.35)0.745
PPSS day 2, mean15.6 (SD = 7.2)16.5 (SD = 9.1)0.425
VAS day 3, mean1.44 (SD = 1.64)1.61 (SD = 1.65)0.514
VAS day 3, min1.10 (SD = 1.39)1.21 (SD = 1.48)0.619
VAS day 3, max1.76 (SD = 2.11)2.05 (SD = 2.10)0.375
PPSS day 3, mean8.4 (SD = 6.7)9.4 (SD = 7.6)0.305
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kanellos, P.; Nirgianakis, K.; Siegenthaler, F.; Vetter, C.; Mueller, M.D.; Imboden, S. Postoperative Pain Is Driven by Preoperative Pain, Not by Endometriosis. J. Clin. Med. 2021, 10, 4727. https://doi.org/10.3390/jcm10204727

AMA Style

Kanellos P, Nirgianakis K, Siegenthaler F, Vetter C, Mueller MD, Imboden S. Postoperative Pain Is Driven by Preoperative Pain, Not by Endometriosis. Journal of Clinical Medicine. 2021; 10(20):4727. https://doi.org/10.3390/jcm10204727

Chicago/Turabian Style

Kanellos, Panagiotis, Konstantinos Nirgianakis, Franziska Siegenthaler, Christian Vetter, Michael D. Mueller, and Sara Imboden. 2021. "Postoperative Pain Is Driven by Preoperative Pain, Not by Endometriosis" Journal of Clinical Medicine 10, no. 20: 4727. https://doi.org/10.3390/jcm10204727

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop